Fluidigm Q2 Revenues Dip 2 Percent on Lower Instrument Sales | GenomeWeb

NEW YORK (GenomeWeb) - Fluidigm said after the close of the market on Thursday that its second quarter revenues decreased 2 percent year over year.

For the three months ended June 30, the South San Francisco, California-based firm reported revenues of $28.2 million compared to $28.6 million in the second quarter of 2015 and falling short of the consensus Wall Street estimate of $29.6 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.